News GCT Receives Regulatory Green Light in India: Initiates Phase III Trial for Chronic Idiopathic Thrombocytopenic Purpura Oct 6, 2023
News GCT Provides Clinical Trial Auditing Services, Backed by Unparalleled European Expertise Aug 1, 2023
